Francesco De Rubertis

Insider Reports History

Location
Geneva, Switzerland
Signature
/s/ Marella Thorell, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Francesco De Rubertis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Director Ordinary Shares 281K $2.24M $7.96 21 Mar 2022 Indirect
Centessa Pharmaceuticals plc Director Series A Preferred Shares 0 $11.00 02 Jun 2021 Indirect

Insider Reports Filed by Francesco De Rubertis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNTA Centessa Pharmaceuticals plc 21 Mar 2022 2 $0 4 23 Mar 2022 Director
CNTA Centessa Pharmaceuticals plc 02 Dec 2021 2 $440K 4 06 Dec 2021 Director
CNTA Centessa Pharmaceuticals plc 30 Nov 2021 4 $1.19M 4 02 Dec 2021 Director
CNTA Centessa Pharmaceuticals plc 26 Nov 2021 4 $797K 4 30 Nov 2021 Director
CNTA Centessa Pharmaceuticals plc 27 May 2021 0 $0 3 27 May 2021 Director
CNTA Centessa Pharmaceuticals plc 29 Jan 2021 8 $33.2M 4 04 Jun 2021 Director